Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure

被引：412

作者：

Locatelli, F

Aljama, PA

Bárány, P

Canaud, B

Carrera, F

Eckardt, KU

Hörl, WH

Macdougall, IC

Macleod, A

Wiecek, A

Cameron, S

机构：

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2004年 / 19卷

关键词：

D O I：

10.1093/ndt/gfh1024

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：1 / 47

页数：47

共 383 条

[1]

ABELS RI, 1992, SEMIN ONCOL, V19, P29

[2]

ABRAHAM PA, 1991, J AM SOC NEPHROL, V2, P927

[3]

ABUALFA A, 1997, J AM SOC NEPHROL, V8, pA225

[4] EVALUATION OF HEMODIALYSIS-PATIENTS TREATED WITH ERYTHROPOIETIN [J].

ACCHIARDO, SR ;

QUINN, BP ;

MOORE, LW ;

BURK, LB ;

MILES, DE .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 17 (03) :290-294

[5]

Akcicek F, 1997, ADV PERIT D, V13, P109

[6]

AKMAL M, 1994, CLIN NEPHROL, V42, P198

[7] High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients [J].

Albitar, S ;

Genin, R ;

Fen-Chong, M ;

Serveaux, MO ;

Bourgeon, B .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (05) :1206-1210

[8] SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION OF ERYTHROPOIETIN IMPROVES ITS EFFICIENCY FOR THE TREATMENT OF ANEMIA IN HEMODIALYSIS-PATIENTS [J].

ALBITAR, S ;

MEULDERS, Q ;

HAMMOUD, H ;

SOUTIF, C ;

BOUVIER, J ;

POLLINI, J .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 :40-43

[9]

Amann K, 2001, J CLIN BAS CARDIOL, V4, P109

[10]

Andrews N C, 1999, Curr Opin Hematol, V6, P61, DOI 10.1097/00062752-199903000-00001

← 1 2 3 4 5 6 7 8 9 10 →